Loading
NASDAQIndustrialsIndustrial - Distribution
Latest quote
$1.2493
−$0.0907 · -6.77%
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Latest quote
$1.2493
−$0.0907 · -6.77%
After-hours
$1.27
+$0.0207 · +1.66%
Oct 8, 4:04 PM ET
Regular session · ET · Market data may be delayed.
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Day range
Current $1.2493
52-week range
Current $1.2493
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
47
Fair Value
Sentiment
54
Mixed
Risk
82
Extreme Risk
Momentum
18
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Day range
Current $1.2493
52-week range
Current $1.2493
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.42M USD | 9.51M USD | 9.77M USD | 10.93M USD | 13.36M USD |
| Cost of goods sold | 6.34M USD | 8.22M USD | 8.44M USD | 9.67M USD | 11.17M USD |
| Gross profit | 1.09M USD | 1.29M USD | 1.33M USD | 1.26M USD | 2.19M USD |
| Research and development | 50.67K USD | 47.51K USD | 54.98K USD | — | — |
| Selling, general, and administrative | 4.07M USD | 4M USD | 3.04M USD | 1.73M USD | 1.2M USD |
| Operating expenses | 4.24M USD | 2.86M USD | 3.92M USD | 1.55M USD | 1.14M USD |
| Interest income | 83.89K USD | 147.64K USD | — | — | — |
| Interest expense | 19.54K USD | 21.15K USD | 13.93K USD | 12.48K USD | 12.97K USD |
| Depreciation and amortization | 168.31K USD | 153.14K USD | 108.42K USD | 105.42K USD | 108.22K USD |
| Operating income | −3.16M USD | −1.57M USD | −2.59M USD | −291.18K USD | 1.06M USD |
| Net income | −2.98M USD | −1.6M USD | −2.63M USD | −355.97K USD | 751.57K USD |
Company facts updated Oct 8, 2026.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
